<html>
   <head>
      <meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
   
      <meta content="Percussion Rhythmyx" name="generator">
      <title>The Structure of an Important Drug Target Made Crystal Clear: National Institute of Neurological Disorders and Stroke (NINDS)</title>
      <link rel="stylesheet" type="text/css" href="/web_resources/ninds_style.css">
      <link rel="alternate stylesheet" title="text" type="text/css" href="/web_resources/text_style.css">
      <link rel="alternate stylesheet" title="print" type="text/css" href="/web_resources/print_style.css"><script language="javascript" type="text/javascript" src="/web_resources/public.js"></script><meta content="stroke, brain, neuroscience, strokes, brain attack, neurology, NIH, neurological disorder, brain disorder, stroke prevention, neurology funding, shingles, disorders, brain disorders, neuroscience funding, Alzheimer, National Institute of Neurological Disorders and Stroke, neuroscience research, Alzheimer's, epilepsy, nervous system, neuroscience news, clinical trials, neurology research, Parkinson's, biomedical research, brain research, multiple sclerosis, autism, NINDS" name="KEYWORDS">
      <meta content="The National Institute of Neurological Disorders and Stroke (NINDS) is the leading supporter of biomedical research on disorders of the brain and nervous system." name="DESCRIPTION">
      <meta name="PRIORITY" content="0">
   </head>
   <body>
      <div id="pageWrapper">
         <div id="toplinks"><a href="http://espanol.ninds.nih.gov/">En Espa&ntilde;ol</a> | <span class="graphical_only"><a href="http://accessible.ninds.nih.gov/">Plain Text Version</a>  | </span><a href="#skipnav">Skip Navigation</a><br><span class="textonly"><label for="search">Search this site:</label></span><form action="http://search2.google.cit.nih.gov/search" method="get" name="search"><input name="site" type="hidden" value="NINDS"><input name="client" type="hidden" value="NINDS_frontend"><input name="proxystylesheet" type="hidden" value="NINDS_frontend"><input name="output" type="hidden" value="xml_no_dtd"><input name="filter" type="hidden" value="0"><input name="getfields" type="hidden" value="*"><input name="proxyreload" type="hidden" value="1"><input class="topsearchtext" id="search" maxlength="30" name="q" size="30" type="text"><button class="topsearchbtn2" onmouseout="this.className='topsearchbtn2'" onmouseover="this.className='topsearchbtn2 topsearchbtnhover2'" type="submit" value="Search">Search</button></form>
         </div>
         <div id="header"><a href="/"><img alt="National Institute of Neurological Disorders and Stroke Logo" border="0" src="/img/NINDS-Logo.jpg"></a><a class="nih" href="http://www.nih.gov/"><img alt="National Institutes of Health" border="0" src="/img/NIH-Link.jpg"></a></div>
         <div id="contentContainer">
            <p class="breadcrumb">You are here:&nbsp;
               <a href="/index.htm">Home</a>&nbsp;&raquo;&nbsp;<a href="/news_and_events/index.htm">News From NINDS</a>&nbsp;&raquo;&nbsp;<a href="/news_and_events/news_articles/index.htm">News Articles</a>&nbsp;&raquo;&nbsp;
            </p>
            <div id="outerColumnContainer">
               <div id="innerColumnContainer">
                  <h1 class="displaytitle">The Structure of an Important Drug Target Made Crystal Clear</h1><span class="textonly"><a href="#contentColumn">Skip secondary menu</a></span><div id="leftColumn">
                     <div class="inside">
                        <!--infoLink is: http://127.0.0.1:9992/Rhythmyx/rxs_Navon_cas/navon.xml?sys_revision=17&sys_siteid=307&sys_authtype=1&sys_contentid=752&sys_variantid=394&pssessionid=51ddfcfc7844d097b27ef92eda0b736c3fd62067&sys_context=1-->
                        <div class="menu_section">
                           <p><a href="/index.htm">Home</a></p>
                        </div>
                        <div class="menu_section">
                           <p><a href="/disorders/disorder_index.htm">Disorders A - Z</a></p>
                        </div>
                        <div class="menu_active">
                           <p><a href="/news_and_events/index.htm">News From NINDS</a></p>
                        </div>
                        <div class="lsbGroup">
                           <!--This id is: 552; The list of matching ids is: 29944,919,34713,--><a href="/news_and_events/press_releases/index.htm">Press Releases</a><br>
                           <!--This id is: 919; The list of matching ids is: 29944,919,34713,-->
                           <!--popsicle-Graphical a[id]: 919; -->
                           <!--matchFlag Yes--><div class="lsbfocus">
                              <!--Highlight here--><a href="/news_and_events/news_articles/index.htm">News Articles</a></div>
                           <!--popsicle-Graphical a[id]: 4179; -->
                           <!--This id is: 4179; The list of matching ids is: 29944,919,34713,--><a href="/funding/nindsnotes/index.htm">Funding News</a></div>
                        <div class="lsbGroup"><span class="lsbheader">Events</span><br>
                           <!--This id is: 5456; The list of matching ids is: 29944,919,34713,--><a href="/news_and_events/events/index.htm">Calendar of Events</a><br>
                           <!--This id is: 4924; The list of matching ids is: 29944,919,34713,--><a href="/news_and_events/proceedings/index.htm">Proceedings</a><br>
                           <!--This id is: 5628; The list of matching ids is: 29944,919,34713,--><a href="/news_and_events/congressional_testimony/index.htm">Congressional </a><br>
                           <!--This id is: 5628; The list of matching ids is: 29944,919,34713,-->&nbsp;&nbsp;&nbsp;<a href="/news_and_events/congressional_testimony/index.htm">Testimony</a></div>
                        <div class="menu_section">
                           <p><a href="/funding/index.htm">Research Funding</a></p>
                        </div>
                        <div class="menu_section">
                           <p><a href="/funding/areas/training_and_career_development/index.htm">Training &amp; Career Awards</a></p>
                        </div>
                        <div class="menu_section">
                           <p><a href="/research/index.htm">Research Programs</a></p>
                        </div>
                        <div class="menu_section">
                           <p><a href="/find_people/index.htm">Find People</a></p>
                        </div>
                        <div class="menu_section">
                           <p><a href="/about_ninds/index.htm">About NINDS</a></p>
                        </div>
                        <div class="landingPageIDSet"></div>
                        <div class="lsblastlinks"><a name="skipnav"></a></div>
                        <div class="linksleft"><img alt="Email Icon" border="0" height="20" src="/img/email_icon.gif" width="20">&nbsp; <a href="/apps/email.aspx?PageTitle=The Structure of an Important Drug Target Made Crystal Clear">Email this page</a><br><img alt="Print Icon" border="0" height="20" src="/img/print_icon.gif" width="20">&nbsp; <a href="?css=print">Print-friendly version</a><br id="XSpLit75"><img alt="Adobe Reader Icon" border="0" height="20" width="20" src="/img/pdf_icon.gif">&nbsp; <a href="http://www.adobe.com/products/acrobat/readstep2.html">Download Adobe Reader</a></div>
                     </div>
                  </div>
                  <div id="contentColumn">
                     <div class="inside">
                        <p>For release: Wednesday, December 05, 2007</p>
                        <p xmlns:o="urn:www.microsoft.com/office" xmlns:st1="urn:www.microsoft.com/smarttags" xmlns:w="urn:www.microsoft.com/word">Scientists have produced detailed 3-dimensional images of a common type of neurotransmitter receptor, the class of proteins
                           on the receiving end of chemical signals in the nervous system.&nbsp; The work, funded by the National Institutes of Health (NIH),
                           is expected to speed the development of drugs for a variety of neurological and psychiatric disorders.
                        </p>
                        <p xmlns:o="urn:www.microsoft.com/office" xmlns:st1="urn:www.microsoft.com/smarttags" xmlns:w="urn:www.microsoft.com/word">In three papers, the researchers published atomic-scale views of the beta2-adrenergic receptor, a protein on the surface of
                           smooth muscle cells.&nbsp; It's a receptor for adrenalin &#8211; the neurochemical behind the body's fight-or-flight response &#8211; and a
                           target for drugs used to treat a variety of conditions including asthma and preterm labor.&nbsp; It's also one of many structurally
                           related proteins known as G-protein-coupled receptors, which include several types of neurotransmitter receptors that are
                           abundant in the brain.
                        </p>
                        <p xmlns:o="urn:www.microsoft.com/office" xmlns:st1="urn:www.microsoft.com/smarttags" xmlns:w="urn:www.microsoft.com/word">The research was supported by the National Institute of Neurological Disorders and Stroke (NINDS), the National Institute
                           of General Medical Sciences (NIGMS), and the NIH Roadmap.&nbsp; Launched in 2004, the Roadmap's Innovative Membrane Protein Technology
                           initiative supports research to better understand the structure of proteins found in the outer membrane of neurons, muscle
                           cells and other cell types.
                        </p>
                        <p xmlns:o="urn:www.microsoft.com/office" xmlns:st1="urn:www.microsoft.com/smarttags" xmlns:w="urn:www.microsoft.com/word">"These studies were filled with technical challenges, but the investigators were able to overcome them thanks to the Roadmap's
                           focused investment in membrane protein research," says NINDS Director Story Landis, Ph.D.&nbsp; "This is only the beginning of
                           the pay-off that the Roadmap will bring to neuroscience."
                        </p>
                        <p xmlns:o="urn:www.microsoft.com/office" xmlns:st1="urn:www.microsoft.com/smarttags" xmlns:w="urn:www.microsoft.com/word">Structural biologists probe the anatomy of proteins using a technique called X-ray crystallography, which involves crystallizing
                           the proteins and bouncing X-rays off of them.&nbsp; Most G-protein-coupled receptors are notoriously difficult to crystallize,
                           however, because they are constantly changing shape.&nbsp; The receptors are active even in the absence of a stimulus like adrenalin.&nbsp;
                           Their parts are in continuous motion, transmitting information from outside the cell to inside through their tiny, even more
                           mobile partners the G-proteins.
                        </p>
                        <p xmlns:o="urn:www.microsoft.com/office" xmlns:st1="urn:www.microsoft.com/smarttags" xmlns:w="urn:www.microsoft.com/word">Until now, the only G-protein-coupled receptor to be successfully examined by X-ray crystallography was rhodopsin, the protein
                           that enables cells in the retina to respond to light.&nbsp; Unlike its shape-shifting relatives, rhodopsin's structure is stable
                           in the absence of its stimulus (light), a feature believed to be important for visual acuity.&nbsp; As an early step in drug development,
                           researchers have tried using rhodopsin's structure to model the structure of other G-protein-coupled-receptors, but rhodopsin's
                           uniqueness made those attempts problematic.
                        </p>
                        <p xmlns:o="urn:www.microsoft.com/office" xmlns:st1="urn:www.microsoft.com/smarttags" xmlns:w="urn:www.microsoft.com/word">"An accurate understanding of the structure of G-protein-coupled receptors will facilitate the drug discovery process" says
                           Brian Kobilka, M.D., a molecular physiologist at Stanford University who led the three new studies on the beta2-adrenergic
                           receptor.&nbsp; Dr. Kobilka is a recipient of the NINDS Javitz award.
                        </p>
                        <p xmlns:o="urn:www.microsoft.com/office" xmlns:st1="urn:www.microsoft.com/smarttags" xmlns:w="urn:www.microsoft.com/word">Dr. Kobilka and his colleagues at Stanford used two methods to stabilize the beta2-adrenergic receptor and render it easier
                           to crystallize.&nbsp; In work published in <i>Nature</i><a href="#Nature">*</a>, they used an antibody to lock onto a flexible piece of the receptor and make it more rigid.&nbsp; In two studies published in
                           <i>Science</i><a href="#Science">**</a>, they used recombinant DNA technology to replace the same flexible piece of the receptor with a small, stable protein. Crystallization
                           experiments on this modified receptor were done in collaboration with Raymond Stevens, Ph.D., and colleagues at Scripps Research
                           Institute in La Jolla.
                        </p>
                        <p xmlns:o="urn:www.microsoft.com/office" xmlns:st1="urn:www.microsoft.com/smarttags" xmlns:w="urn:www.microsoft.com/word">The studies reveal important differences between the beta2-adrenergic receptor's actual structure and its predicted structure
                           based on rhodopsin.&nbsp; For one, it has a more open structure than rhodopsin, Dr. Kobilka says.&nbsp; "The regions that span the membrane
                           aren't bundled as tightly together.&nbsp; We believe that this contributes to the receptor's basal activity."&nbsp; This finding is
                           noteworthy, he says, because the receptor's basal activity &#8211; not just its adrenalin-dependent activity &#8211; could be a target
                           for drug modulation.&nbsp;
                        </p>
                        <p xmlns:o="urn:www.microsoft.com/office" xmlns:st1="urn:www.microsoft.com/smarttags" xmlns:w="urn:www.microsoft.com/word">The methods Dr. Kobilka developed could be used to study other G-protein-coupled neurotransmitter receptors that play roles
                           in depression, Parkinson's disease, epilepsy, stroke and other conditions.
                        </p>
                        <p xmlns:o="urn:www.microsoft.com/office" xmlns:st1="urn:www.microsoft.com/smarttags" xmlns:w="urn:www.microsoft.com/word" id="#Nature">*Rasmussen SGF <i>et al</i>.&nbsp; "Crystal Structure of the Human beta2-Adrenergic G-Protein-Coupled Receptor."&nbsp; <i>Nature</i>, November 15, 2007, Vol. 450, pp. 383-387.
                        </p>
                        <p xmlns:o="urn:www.microsoft.com/office" xmlns:st1="urn:www.microsoft.com/smarttags" xmlns:w="urn:www.microsoft.com/word" id="#Science">**Cherezov V <i>et al</i>.&nbsp; "High-Resolution Crystal Structure of an Engineered Human beta2-Adrenergic G-Protein-Coupled Receptor."&nbsp; <i>Science</i>, November 23, 2007, Vol. 318, pp. 1258-1265.
                        </p>
                        <p xmlns:o="urn:www.microsoft.com/office" xmlns:st1="urn:www.microsoft.com/smarttags" xmlns:w="urn:www.microsoft.com/word">**Rosenbaum DM <i>et al</i>.&nbsp; "GPCR Engineering Yields High-Resolution Structural Insights into beta2-Adrenergic Receptor Function."&nbsp; <i>Science</i>, <i>Science</i>, November 23, 2007, Vol. 318, pp. 1266-1273.
                        </p>
                        <p xmlns:o="urn:www.microsoft.com/office" xmlns:st1="urn:www.microsoft.com/smarttags" xmlns:w="urn:www.microsoft.com/word"><i>-By Daniel Stimson, Ph.D.</i></p><br id="XSpLit95">
                        Date Last Modified: Wednesday, December 05, 2007
                        <hr id="XSpLit97">
                     </div>
                  </div>
               </div>
            </div>
            <div id="footer"><br clear="all"><hr>
               <p align="center" class="tinytext">
                  National Institute of Neurological Disorders and Stroke<br><a href="/index.htm">Home</a>&nbsp;|&nbsp;<a href="/about_ninds/index.htm">About NINDS</a>&nbsp;|&nbsp;<a href="/disorders/disorder_index.htm">Disorders A - Z</a>&nbsp;|&nbsp;<a href="/funding/index.htm">Research Funding</a>&nbsp;|&nbsp;<i><a href="/news_and_events/index.htm">News From NINDS</a>&nbsp;|&nbsp;</i><a href="/find_people/index.htm">Find People</a>&nbsp;|&nbsp;<a href="/funding/areas/training_and_career_development/index.htm">Training</a>&nbsp;|&nbsp;<a href="/research/index.htm">Research</a>&nbsp;
                  
               </p>
               <p align="center" class="tinytext">
                  <a class="footer_lnks" href="http://www.ninds.nih.gov/jobs_and_training/index.htm">Careers@NINDS</a>
                  | 
                  <a class="footer_lnks" href="http://www.nih.gov/icd/od/foia/index.htm">FOIA (NIH)</a>
                  | 
                  <a class="footer_lnks" href="/accessible/access_instructions.htm">
                     
                     Accessibility Policy
                     
                     </a>
                  | <a class="footer_lnks" href="/about_ninds/addresses.htm">Contact Us</a> | <a class="footer_lnks" href="/privacy.htm">Privacy Statement</a>&nbsp;
                  
               </p>
               <p align="center"><a href="http://www.hhs.gov/"><img alt="H H S Logo - link to U. S. Department of Health and Human Services" border="0" src="/img/logo_dhhs.gif"></a> &nbsp;&nbsp;&nbsp;
                  <a href="http://www.nih.gov/"><img alt="N I H logo - link to U. S. National Institutes of Health" border="0" src="/img/nihsmall.gif"></a>&nbsp;&nbsp;&nbsp;
                  <a href="http://www.usa.gov/"><img alt="Usa.gov Logo - USA.gov is the U.S. government's official web portal to all federal, state and local government web resources and services." border="0" src="/img/usagov_logo.gif"></a></p>
            </div>
         </div>
      </div>
   </body>
</html>